{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:49:46Z","timestamp":1791946186317,"version":"4.3.4"},"reference-count":113,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1212\/con.0000000000001345","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:04:48Z","timestamp":1697627088000},"page":"1538-1563","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases"],"prefix":"10.1212","volume":"29","author":[{"given":"Aaron","family":"Izenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000351153"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.1949021"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.2023190"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.183525"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21653"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304724"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/2192568218813916"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S37505"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000148649.17706.D9"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00465-8"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315622"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000055861.95202.8d"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008063"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000172911.39167.b6"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1267768"},{"key":"e_1_3_1_17_2","unstructured":"The Ohio State University Wexner Medical Center. Ohio State establishing national standards for ALS genetic testing research and patient care. Accessed July 25 2023. wexnermedical.osu.edu\/departments\/innovations\/neuronews\/alsguidelines"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2015.07.006"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000200962.94777.71"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322541"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23496"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.235952"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c1dea3"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2015.07.003"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345041.83406.a2"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/17482960903513159"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200010)23:10<1488::aid-mus4>3.0.co;2-e"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2017.04.008"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116440"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170281"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-5101.2003.00697.x"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/146608200300079536"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2007.09.143"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2020.04.005"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26045"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30401-5"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr296"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3584"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00414-2"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2020-106866"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2044"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/14660820050515377"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-022-01055-8"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.011"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.010"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000575"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0047-2"},{"key":"e_1_3_1_48_2","unstructured":"US Food and Drug Administration. FDA approves new treatment option for patients with ALS. Accessed August 1 2023. fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-option-patients-als"},{"key":"e_1_3_1_49_2","unstructured":"ClinicalTrials.gov. A study of BIIB067 (tofersen) initiated in clinically presymptomatic adults with a confirmed superoxide dismutase 1 mutation (ATLAS) (NCT04856982). Updated July 17 2023. Accessed July 28 2023. clinicaltrials.gov\/ct2\/show\/NCT04856982"},{"key":"e_1_3_1_50_2","unstructured":"ClinicalTrials.gov. A study to assess the safety tolerability and pharmacokinetics of BIIB078 in adults with C9ORF72-associated amyotrophic lateral sclerosis (NCT03626012). Updated January 14 2022. Accessed July 28 2023. clinicaltrials.gov\/ct2\/show\/NCT03626012"},{"key":"e_1_3_1_51_2","unstructured":"ClinicalTrials.gov. Study of WVE-004 in patients with C9orf72-associated amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD) (FOCUS-C9) (NCT04931862). Updated February 3 2023. Accessed July 28 2023. clinicaltrials.gov\/ct2\/show\/NCT04931862"},{"key":"e_1_3_1_52_2","unstructured":"ClinicalTrials.gov. A study to assess the safety tolerability and effect on disease progression of BIIB105 in participants with amyotrophic lateral sclerosis (ALS) and participants with the ALS Ataxin-2 (ATXN2) genetic mutation (ALSpire) (NCT04494256). Updated June 15 2023. Accessed July 28 2023. clinicaltrials.gov\/ct2\/show\/NCT04494256"},{"key":"e_1_3_1_53_2","unstructured":"ClinicalTrials.gov. A study to evaluate the efficacy safety pharmacokinetics and pharmacodynamics of ION363 in amyotrophic lateral sclerosis participants with fused in sarcoma mutations (FUS-ALS) (NCT04768972). Updated March 28 2023. Accessed July 28 2023. clinicaltrials.gov\/ct2\/show\/NCT04768972"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.107"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71601"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1603471"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207166"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300901"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)91680-3"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub3"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2020.1771734"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.959024"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30115-1"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26740"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4893"},{"key":"e_1_3_1_66_2","unstructured":"US Food and Drug Administration. Edaravone. Accessed May 16 2022. accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215446s000lbl.pdf"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916945"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329024"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27569"},{"key":"e_1_3_1_70_2","unstructured":"Government of Canada. Qualifying notice for Albrioza. Accessed August 1 2023. canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/notice-compliance\/conditions\/qualifying-notice-albrioza-253502.html"},{"key":"e_1_3_1_71_2","unstructured":"ClinicalTrials.gov. Phase III trial of AMX0035 for amyotrophic lateral sclerosis treatment (Phoenix). Updated January 6 2023. Accessed August 22 2023. clinicaltrials.gov\/ct2\/show\/NCT05021536"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008620"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27472"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27697"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2003715"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204705"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01615-z"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.191721"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70326-4"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202002-169OC"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bc0141"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2016.1165256"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1361445"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192243"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6534150"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.211474"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1360355"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177555"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02024"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.9.1258"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309601"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180717.29273.12"},{"issue":"5","key":"e_1_3_1_93_2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/CON.0000000000001340","article-title":"Multidisciplinary clinics in neuromuscular medicine","volume":"29","author":"Gwathmey K","year":"2023","unstructured":"Gwathmey K, Heiman-Patterson TD. Multidisciplinary clinics in neuromuscular medicine. Continuum (Minneap Minn) 2023;29(5, Peripheral Nerve and Motor Neuron Disorders):1585\u20131594.","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr351"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306589"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.1903506"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30089-9"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30111-X"},{"issue":"5","key":"e_1_3_1_99_2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1212\/CON.0000000000001338","article-title":"Spinal muscular atrophy","volume":"29","author":"Oskoui M","year":"2023","unstructured":"Oskoui M, Servais L. Spinal muscular atrophy. Continuum (Minneap Minn) 2023;29(5, Peripheral Nerve and Motor Neuron Disorders):1564\u20131584.","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000507"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl096"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01366-z"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880180306"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8968-7"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.811943"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.903976"},{"key":"e_1_3_1_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2018.04.009"},{"key":"e_1_3_1_108_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5577"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-3019(97)00451-5"},{"key":"e_1_3_1_110_2","doi-asserted-by":"publisher","DOI":"10.13107\/jocr.2250-0685.107"},{"issue":"4","key":"e_1_3_1_111_2","first-page":"173","article-title":"Cervical collar therapy for juvenile muscular atrophy of distal upper extremity (Hirayama disease): results from 38 cases","volume":"41","author":"Tokumaru Y","year":"2001","unstructured":"Tokumaru Y, Hirayama K. [Cervical collar therapy for juvenile muscular atrophy of distal upper extremity (Hirayama disease): results from 38 cases]. Rinsho Shinkeigaku 2001;41(4-5):173\u2013178.","journal-title":"Rinsho Shinkeigaku"},{"key":"e_1_3_1_112_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-021-01540-2"},{"key":"e_1_3_1_113_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.3.189"},{"key":"e_1_3_1_114_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00773"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000001345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:04:39Z","timestamp":1752156279000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1212\/CON.0000000000001345"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000001345","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}